Ultrafiltration may not be best approach for heart failure patients, research finds

November 7, 2012

Ultrafiltration was no more effective in removing excess fluid from the heart than using standard treatment including diuretics to reduce congestion in heart failure patients, according to late-breaking clinical trial research presented at the American Heart Association Scientific Sessions 2012.

The full manuscript for Cardiorenal Rescue Study in (CARRESS-HF) is published in the .

Excess fluid build-up in the body can occur in many and lead to a need to hospitalize these patients. For decades, physicians have used known as diuretics to remove excess fluid. Many heart failure patients may have some degree of abnormality in kidney function and diuretics can lead to further worsening of kidney function.

"We need better treatments for managing hospitalized heart failure patients, but our findings indicate that ultrafiltration may not be the answer," said Bradley Bart, M.D., lead author of the study and chief of cardiology at Hennepin County Medical Center in Minneapolis, Minn.

In the prospective randomized comparison of the treatments, researchers randomly assigned ultrafiltration or a diuretic-based approach to 188 hospitalized patients (average age 68, mostly male) with persistent excess fluid and worsening kidney function. Eighty-four percent had high blood pressure; 66 percent had diabetes; and 75 percent had at least one recent admission to the hospital for heart failure.

Researchers measured the patients' weight change (as a measure of improved congestion and fluid loss) and kidney function four days after starting treatment, and followed patients for 60 days to see if they remained stable and out of the hospital.

Both groups lost about 12 pounds during the first four days of treatment. worsened in ultrafiltration patients and they also had more side effects. After 60 days, there were no differences between the two groups in either heart failure hospitalizations or death.

"Ultrafiltration is more expensive, more complex and doesn't offer any advantage as administered in this study," Bart said.

"The overall disappointing results of this trial indicate that more research is needed to find better ways to treat these seriously ill patients," said Eugene Braunwald, co-author and chair of the Heart Failure Network that conducted the study.

Explore further: Clinical trial examines benefits of, mechanisms behind ultrafiltration for heart failure

Related Stories

New genetic target found for diuretic therapy

July 30, 2012

Researchers at the University of Cincinnati (UC) have identified a new genetic target for diuretic therapy in patients with fluid overload—like those with congestive heart failure, liver cirrhosis or kidney failure.

Recommended for you

Researchers find sleep gene linked to heart failure

November 30, 2015

Researchers at the Stanford University School of Medicine have identified a gene that, when working properly, appears to reduce the risk of heart failure and improve treatment outcomes, highlighting a possible target for ...

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.